Fiera Capital Corp bought a new position in Pro-Dex, Inc. (NASDAQ:PDEX) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 12,000 shares of the medical instruments supplier’s stock, valued at approximately $323,000.
A number of other hedge funds also recently modified their holdings of PDEX. Hussman Strategic Advisors Inc. purchased a new stake in Pro-Dex in the first quarter worth approximately $194,000. Exchange Traded Concepts LLC purchased a new stake in Pro-Dex in the first quarter worth approximately $540,000. Victory Capital Management Inc. purchased a new stake in Pro-Dex in the first quarter worth approximately $1,379,000. Dimensional Fund Advisors LP boosted its holdings in Pro-Dex by 2.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 52,562 shares of the medical instruments supplier’s stock worth $1,628,000 after purchasing an additional 1,133 shares during the last quarter. Finally, BlackRock Inc. boosted its holdings in Pro-Dex by 2.4% in the first quarter. BlackRock Inc. now owns 60,641 shares of the medical instruments supplier’s stock worth $1,635,000 after purchasing an additional 1,395 shares during the last quarter. Institutional investors own 22.40% of the company’s stock.
In other news, CFO Alisha Charlton sold 978 shares of Pro-Dex stock in a transaction on Tuesday, May 25th. The shares were sold at an average price of $33.90, for a total transaction of $33,154.20. Following the transaction, the chief financial officer now owns 4,774 shares in the company, valued at approximately $161,838.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 40.80% of the company’s stock.
Pro-Dex (NASDAQ:PDEX) last issued its quarterly earnings results on Friday, May 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.22 by $0.28. The business had revenue of $11.74 million for the quarter. Pro-Dex had a net margin of 15.47% and a return on equity of 30.20%.
Pro-Dex, Inc designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and maxocranial facial markets.
Featured Story: Mutual funds are not immune from market timing
Want to see what other hedge funds are holding PDEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pro-Dex, Inc. (NASDAQ:PDEX).
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.